CJC-1295 No DAC + Ipamorelin
⚠️ Disclaimer: For Research Use Only. Not for human administration or clinical therapy.
This stack is a physical blend of two separate synthetic peptides: CJC-1295 without DAC + Ipamorelin. Not a single molecule.
Individual Components Specs
1. CJC-1295 (No DAC, also called CJC-1295-DAC-free)
- CAS: 863280-08-0
- Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
- MW: 3367.04 g/mol
Note: No DAC = without the 2-maleimidopropionyl group (DAC linker). Shorter half-life vs DAC version.
2. Ipamorelin
- CAS: 170851-70-4
- Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
- MW: 711.88 g/mol
Blend Basic Info
- Common formulation ratio: CJC-1295 No DAC 2mg + Ipamorelin 2mg (ratio customizable)
- Appearance: White to off-white lyophilized powder
- Solubility: Soluble in bacteriostatic water / sterile water
- Storage: Lyophilized powder stored at -20℃, protected from light and moisture. Avoid repeated freeze-thaw cycles. After reconstitution, refrigerate and use promptly.
Development Background
CJC‑1295 (No DAC) is a modified GHRH analog. The DAC group is removed, so it cannot bind serum albumin, resulting in shorter in-vivo half-life compared to CJC-1295 with DAC. Ipamorelin is a selective ghrelin receptor agonist (GHSR). This dual peptide stack is widely used in growth hormone secretion research.
Mechanism of Action (Research Findings)
- CJC-1295 No DAC (GHRH analog): Stimulates pituitary gland to release growth hormone (GH); increases IGF-1 levels.
- Ipamorelin (GHSR agonist): Selective growth hormone secretagogue, triggers GH release with minimal impact on cortisol / prolactin (lower side effect profile in research models vs GHRP-6).
- Synergy: Dual pathway stimulation: GHRH + GHSR, stronger GH pulsatile release than single peptide alone.
Research Areas
- Growth hormone / IGF-1 endocrine signaling research
- Pituitary hormone secretion studies
- Body composition & muscle metabolism animal models
- Sleep and tissue repair research
- Comparative pharmacology of GHRH & ghrelin receptor agonists








评价
目前还没有评价